The Indian research-based pharmaceutical company MSN Group is expanding at the quickest rate.
This Hyderabad-based company was founded in 2003 with the goal of lowering the cost of healthcare. To date, it has established 15 API and 6 finished dosage facilities throughout India and the USA.
The organization is committed to researching and developing pharmaceuticals to make them more accessible, and it has an integrated R&D center for both API and formulation under one roof. Putting a primary emphasis on delivery consistency and speed,
MSN has accomplished the subsequent:
More than 900 domestic and foreign patents
Product portfolio with more than 300 formulas and more than 450 APIs covering more than 35 major therapies
gained the confidence of over 40 million patients in more than 80 countries worldwide
Business strategy is centered around innovation and speed. The organizational environment at MSN, which is supported by a committed and knowledgeable staff of over 14,000 people, effectively integrates various disciplines and functions through the use of technology in conjunction with integrity, imagination, and innovation.